Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,063 followers.

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus by Zaid Taha https://t.co/aZ0DOc7uZ8

08 May 2023

Reply Repost Favourite

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus https://t.co/rb9nAZPbqX

08 May 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine c…

20 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.